Skip to main content

Table 4 Observed and expected number of diarrhoea cases

From: Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data

Year

Expected (sample prediction)

Observed

%

All

Acute

Persistent

All

Acute

Persistent

All

2015

953,402

894,294

59,108

953,402

894,294

59,108

0

2016

1,774,428

1,662,915

111,512

1,749,880

1,640,932

108,948

1.4

2017

1,692,427

1,591,136

101,291

1,702,281

1,601,296

100,985

(−)0.6

Rotavirus vaccine introduced in the EPI in 2018: it is available in the public sector

2018

2,218,042

1,985,920

232,122

1,525,899

1,438,138

87,761

31

2019

2,242,588

1,987,474

255,114

1,558,344

1,478,146

80,198

31

2020

2,502,746

2,185,794

316,952

1,330,739

1,275,870

54,869

47

2021

2,900,421

2,484,846

415,575

1,254,846

1,202,629

52,217

57